NextFin news, On Thursday, September 25, 2025, U.S. President Donald Trump announced a new set of import tariffs targeting pharmaceuticals, heavy trucks, kitchen cabinets, and furniture, which will take effect on October 1, 2025. The announcement was made via posts on his social media platform Truth Social.
Trump declared a 100% tariff on branded and patented pharmaceutical products imported into the United States, with an exemption for companies that are currently building pharmaceutical manufacturing plants in the U.S., defined as either "breaking ground" or "under construction." The tariffs aim to encourage domestic production of pharmaceuticals.
In addition, a 25% tariff will be imposed on imported heavy trucks to protect American manufacturers such as Peterbilt, Kenworth, Freightliner, and Mack Trucks from foreign competition. The president stated this move is to shield domestic truck producers from "onslaught of outside interruptions."
Furthermore, a 50% tariff will be applied to kitchen cabinets and bathroom vanities, and a 30% tariff on upholstered furniture. Trump cited national security and other reasons for imposing these tariffs, emphasizing the need to support U.S. manufacturers against foreign imports flooding the market.
The tariffs come amid ongoing concerns about inflation and economic growth. Trump has maintained that inflation is not a challenge, despite data showing a 2.9% increase in the consumer price index over the past year. The tariffs are part of his broader trade policy to reduce the federal budget deficit and promote domestic manufacturing investment.
According to the U.S. Census Bureau, the United States imported nearly $233 billion worth of pharmaceutical and medicinal products in 2024. The new tariffs could lead to increased costs for medicines, potentially impacting healthcare expenses and government programs like Medicare and Medicaid.
The announcement follows previous tariff measures introduced by the Trump administration earlier in 2025, including a 50% combined tariff on various imports and a 25% penalty on Indian purchases of Russian oil. The new tariffs are expected to affect multinational pharmaceutical companies and could have significant implications for exporters, particularly from India, which supplies a large share of generic drugs to the U.S. market.
Trump's administration argues that these tariffs will incentivize companies to invest in U.S. manufacturing facilities, thereby creating jobs and strengthening the domestic economy. However, critics point to recent data showing job cuts in manufacturing and construction sectors since April 2025.
The tariffs on pharmaceuticals, trucks, and furniture will officially commence on October 1, 2025, marking a significant escalation in U.S. trade policy under President Trump.
Explore more exclusive insights at nextfin.ai.
